Mitigation Strategies To Protect Food Against Intentional Adulteration; Draft Guidance for Industry; Availability, 8599-8600 [2020-02986]

Download as PDF Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices Application No. Drug ANDA 065484 .. ANDA 204879 .. Cefuroxime Sodium for Injection, EQ 7.5 g base/vial Pharmacy Bulk Package. Cefuroxime Sodium for Injection, EQ 1.5 g base/vial .............. Prednisolone Sodium Phosphate Oral Solution, EQ 15 mg base/5 milliliters (mL). Acetaminophen, Butalbital, Caffeine, and Codeine Phosphate Capsules, 325 mg, 50 mg, 40 mg, and 30 mg. Ampicillin and Sulbactam for Injection, EQ 1 g base/vial and EQ 500 mg base/vial; EQ 2 g base/vial and EQ 1 g base/ vial. Ampicillin and Sulbactam for Injection, EQ 10 g base/vial and EQ 5 g base/vial. Ampicillin and Sulbactam for Injection, EQ 1 g base/vial and EQ 500 mg base/vial; EQ 2 g base/vial and EQ 1 g base/ vial. Imipenem and Cilastatin for Injection, EQ 250 mg base/vial and 250 mg base/vial; EQ 500 mg base/vial and 500 mg/ vial. Meropenem for Injection, 500 mg/vial, and 1 g/vial ................. Imipenem and Cilastatin for Injection, EQ 500 mg base/vial and 500 mg/vial. Cefepime HCl for Injection, EQ 1 g base/vial; EQ 2 g base/ vial. Ceftriaxone for Injection, EQ 1 g base/vial; EQ 2 g base/vial .. Ampicillin Sodium for Injection, EQ 250 mg base/vial; EQ 500 mg base/vial; EQ 1 g base/vial; EQ 2 g base/vial. Ampicillin Sodium for Injection, EQ 10 g base/vial Pharmacy Bulk Package. Cefotaxime Sodium for Injection, EQ 1 g base/vial; EQ 2 g base/vial. Pyridoxine HCl Injection, 100 mg/mL ....................................... ANDA 206062 .. Doxorubicin HCl for Injection, USP, 20 mg/vial ........................ ANDA 206195 .. Daunorubicin HCl for Injection, EQ 20 mg base/vial ................ ANDA 065503 .. ANDA 075250 .. ANDA 075618 .. ANDA 090375 .. ANDA 090646 .. ANDA 090653 .. ANDA 090825 .. ANDA 090940 .. ANDA 091007 .. ANDA 202268 .. ANDA 202563 .. ANDA 202864 .. ANDA 202865 .. ANDA 203132 .. khammond on DSKJM1Z7X2PROD with NOTICES Therefore, approval of the applications listed in the table, and all amendments and supplements thereto, is hereby withdrawn as of March 16, 2020. Approval of each entire application is withdrawn, including any strengths or products inadvertently missing from the table. Introduction or delivery for introduction into interstate commerce of products without approved new drug applications violates section 301(a) and (d) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 331(a) and (d)). Drug products that are listed in the table that are in inventory on March 16, 2020 may continue to be dispensed until the inventories have been depleted or the drug products have reached their expiration dates or otherwise become violative, whichever occurs first. Dated: February 11, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–03025 Filed 2–13–20; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 16:56 Feb 13, 2020 Jkt 250001 8599 Applicant Do. Do. Bausch Health US, LLC, 400 Somerset Corporate Blvd., Bridgewater, NJ 08807. Hikma Pharmaceuticals USA Inc., 1809 Wilson Rd., Columbus, OH 43228. Hospira, Inc. Do. Do. Do. Do. Do. Do. Do. Do. Do. Do. Mylan Institutional, LLC, 4901 Hiawatha Dr., Rockford, IL 61103. Hisun Pharmaceutical Hangzhou Co., LTD, 200 Crossing Blvd., 2nd Floor, Bridgewater, NJ 08807. Do. Food and Drug Administration by June 15, 2020 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance. [Docket No. FDA–2018–D–1398] ADDRESSES: Mitigation Strategies To Protect Food Against Intentional Adulteration; Draft Guidance for Industry; Availability Electronic Submissions DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. The Food and Drug Administration (FDA, we, or Agency) is announcing the availability of a supplemental draft guidance for industry entitled ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration: Guidance for Industry.’’ This supplemental draft guidance document, when finalized, will help food facilities that manufacture, process, pack, or hold food, and that are required to register under the Federal Food, Drug, and Cosmetic Act (FD&C Act) comply with the requirements of our regulation entitled ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration.’’ DATES: Submit either electronic or written comments on the draft guidance SUMMARY: PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 You may submit comments on any guidance at any time as follows: Submit electronic comments in the following way: • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. Comments submitted electronically, including attachments, to https:// www.regulations.gov will be posted to the docket unchanged. Because your comment will be made public, you are solely responsible for ensuring that your comment does not include any confidential information that you or a third party may not wish to be posted, such as medical information, your or anyone else’s Social Security number, or confidential business information, such as a manufacturing process. Please note that if you include your name, contact information, or other information that identifies you in the body of your comments, that information will be posted on https://www.regulations.gov. E:\FR\FM\14FEN1.SGM 14FEN1 8600 Federal Register / Vol. 85, No. 31 / Friday, February 14, 2020 / Notices khammond on DSKJM1Z7X2PROD with NOTICES • If you want to submit a comment with confidential information that you do not wish to be made available to the public, submit the comment as a written/paper submission and in the manner detailed (see ‘‘Written/Paper Submissions’’ and ‘‘Instructions’’). Written/Paper Submissions Submit written/paper submissions as follows: • Mail/Hand Delivery/Courier (for written/paper submissions): Dockets Management Staff (HFA–305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. • For written/paper comments submitted to the Dockets Management Staff, FDA will post your comment, as well as any attachments, except for information submitted, marked and identified, as confidential, if submitted as detailed in ‘‘Instructions.’’ Instructions: All submissions received must include the Docket No. FDA– 2018–D–1398 for ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration: Guidance for Industry.’’ Received comments will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through Friday. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management Staff. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access VerDate Sep<11>2014 16:56 Feb 13, 2020 Jkt 250001 the information at: https:// www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. You may submit comments on any guidance at any time (see 21 CFR 10.115(g)(5)). Submit written requests for single copies of the guidance to the Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740. Send two self-addressed adhesive labels to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the draft guidance document. FOR FURTHER INFORMATION CONTACT: Ryan Newkirk, Center for Food Safety and Applied Nutrition (HFS–005), Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, 240–402– 3712, ryan.newkirk@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111–353) enables FDA to better protect public health by helping to ensure the safety and security of the food supply. FSMA enables FDA to focus more on preventing food safety problems rather than relying primarily on reacting to problems after they occur. FSMA added to the FD&C Act several new sections that reference intentional adulteration. For example, section 418 of the FD&C Act (21 U.S.C. 350g) addresses intentional adulteration in the context of facilities that manufacture, process, pack, or hold food, and that are required to register under section 415 (21 U.S.C. 350d). Section 420 of the FD&C Act (21 U.S.C. 350i) addresses intentional adulteration in the context of high-risk foods and exempts farms except for farms that produce milk. We are announcing the availability of a supplemental draft guidance for industry entitled ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration: Guidance for Industry.’’ This multi-chapter supplemental draft guidance for industry is intended to help food facilities required to comply develop and implement some of the components of a food defense plan, and meet other requirements under 21 CFR PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 part 121. We are announcing the availability of the following chapters and appendices: • Chapter 5—Mitigation Strategies Management Components: Food Defense Corrective Actions • Chapter 6—Mitigation Strategies Management Components: Food Defense Verification • Chapter 7—Reanalysis • Chapter 9—Records • Appendix 2—Mitigation Strategies in the Food Defense Mitigation Strategies Database • Appendix 3—Determination of Status as a Very Small Business or Small Business Under Part 121: Mitigation Strategies to Protect Food Against Intentional Adulteration II. Significance of Guidance This level 1 draft guidance is being issued consistent with FDA’s good guidance practices regulation (21 CFR 10.115). The draft guidance, when finalized, will represent the current thinking of FDA on food defense measures against intentional adulteration for the regulation ‘‘Mitigation Strategies to Protect Food Against Intentional Adulteration.’’ It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. III. Paperwork Reduction Act of 1995 This draft guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501–3520). The collections of information in 21 CFR part 121 have been approved under OMB control number 0910–0812. IV. Electronic Access Persons with access to the internet may obtain the draft guidance at either https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments or https:// www.regulations.gov. Use the FDA website listed in the previous sentence to find the most current version of the guidance. Dated: February 10, 2020. Lowell J. Schiller, Principal Associate Commissioner for Policy. [FR Doc. 2020–02986 Filed 2–13–20; 8:45 am] BILLING CODE 4164–01–P E:\FR\FM\14FEN1.SGM 14FEN1

Agencies

[Federal Register Volume 85, Number 31 (Friday, February 14, 2020)]
[Notices]
[Pages 8599-8600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02986]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-D-1398]


Mitigation Strategies To Protect Food Against Intentional 
Adulteration; Draft Guidance for Industry; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, we, or Agency) is 
announcing the availability of a supplemental draft guidance for 
industry entitled ``Mitigation Strategies to Protect Food Against 
Intentional Adulteration: Guidance for Industry.'' This supplemental 
draft guidance document, when finalized, will help food facilities that 
manufacture, process, pack, or hold food, and that are required to 
register under the Federal Food, Drug, and Cosmetic Act (FD&C Act) 
comply with the requirements of our regulation entitled ``Mitigation 
Strategies to Protect Food Against Intentional Adulteration.''

DATES: Submit either electronic or written comments on the draft 
guidance by June 15, 2020 to ensure that the Agency considers your 
comment on this draft guidance before it begins work on the final 
version of the guidance.

ADDRESSES: You may submit comments on any guidance at any time as 
follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments. Comments submitted 
electronically, including attachments, to https://www.regulations.gov 
will be posted to the docket unchanged. Because your comment will be 
made public, you are solely responsible for ensuring that your comment 
does not include any confidential information that you or a third party 
may not wish to be posted, such as medical information, your or anyone 
else's Social Security number, or confidential business information, 
such as a manufacturing process. Please note that if you include your 
name, contact information, or other information that identifies you in 
the body of your comments, that information will be posted on https://www.regulations.gov.

[[Page 8600]]

     If you want to submit a comment with confidential 
information that you do not wish to be made available to the public, 
submit the comment as a written/paper submission and in the manner 
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand Delivery/Courier (for written/paper 
submissions): Dockets Management Staff (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets 
Management Staff, FDA will post your comment, as well as any 
attachments, except for information submitted, marked and identified, 
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No. 
FDA-2018-D-1398 for ``Mitigation Strategies to Protect Food Against 
Intentional Adulteration: Guidance for Industry.'' Received comments 
will be placed in the docket and, except for those submitted as 
``Confidential Submissions,'' publicly viewable at https://www.regulations.gov or at the Dockets Management Staff between 9 a.m. 
and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with 
confidential information that you do not wish to be made publicly 
available, submit your comments only as a written/paper submission. You 
should submit two copies total. One copy will include the information 
you claim to be confidential with a heading or cover note that states 
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will 
review this copy, including the claimed confidential information, in 
its consideration of comments. The second copy, which will have the 
claimed confidential information redacted/blacked out, will be 
available for public viewing and posted on https://www.regulations.gov. 
Submit both copies to the Dockets Management Staff. If you do not wish 
your name and contact information to be made publicly available, you 
can provide this information on the cover sheet and not in the body of 
your comments and you must identify this information as 
``confidential.'' Any information marked as ``confidential'' will not 
be disclosed except in accordance with 21 CFR 10.20 and other 
applicable disclosure law. For more information about FDA's posting of 
comments to public dockets, see 80 FR 56469, September 18, 2015, or 
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or 
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in 
the heading of this document, into the ``Search'' box and follow the 
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane, 
Rm. 1061, Rockville, MD 20852.
    You may submit comments on any guidance at any time (see 21 CFR 
10.115(g)(5)).
    Submit written requests for single copies of the guidance to the 
Center for Food Safety and Applied Nutrition, Food and Drug 
Administration, 5001 Campus Dr., College Park, MD 20740. Send two self-
addressed adhesive labels to assist that office in processing your 
requests. See the SUPPLEMENTARY INFORMATION section for electronic 
access to the draft guidance document.

FOR FURTHER INFORMATION CONTACT: Ryan Newkirk, Center for Food Safety 
and Applied Nutrition (HFS-005), Food and Drug Administration, 5001 
Campus Dr., College Park, MD 20740, 240-402-3712, 
[email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111-353) 
enables FDA to better protect public health by helping to ensure the 
safety and security of the food supply. FSMA enables FDA to focus more 
on preventing food safety problems rather than relying primarily on 
reacting to problems after they occur.
    FSMA added to the FD&C Act several new sections that reference 
intentional adulteration. For example, section 418 of the FD&C Act (21 
U.S.C. 350g) addresses intentional adulteration in the context of 
facilities that manufacture, process, pack, or hold food, and that are 
required to register under section 415 (21 U.S.C. 350d). Section 420 of 
the FD&C Act (21 U.S.C. 350i) addresses intentional adulteration in the 
context of high-risk foods and exempts farms except for farms that 
produce milk.
    We are announcing the availability of a supplemental draft guidance 
for industry entitled ``Mitigation Strategies to Protect Food Against 
Intentional Adulteration: Guidance for Industry.'' This multi-chapter 
supplemental draft guidance for industry is intended to help food 
facilities required to comply develop and implement some of the 
components of a food defense plan, and meet other requirements under 21 
CFR part 121. We are announcing the availability of the following 
chapters and appendices:

 Chapter 5--Mitigation Strategies Management Components: Food 
Defense Corrective Actions
 Chapter 6--Mitigation Strategies Management Components: Food 
Defense Verification
 Chapter 7--Reanalysis
 Chapter 9--Records
 Appendix 2--Mitigation Strategies in the Food Defense 
Mitigation Strategies Database
 Appendix 3--Determination of Status as a Very Small Business 
or Small Business Under Part 121: Mitigation Strategies to Protect Food 
Against Intentional Adulteration

II. Significance of Guidance

    This level 1 draft guidance is being issued consistent with FDA's 
good guidance practices regulation (21 CFR 10.115). The draft guidance, 
when finalized, will represent the current thinking of FDA on food 
defense measures against intentional adulteration for the regulation 
``Mitigation Strategies to Protect Food Against Intentional 
Adulteration.'' It does not establish any rights for any person and is 
not binding on FDA or the public. You can use an alternative approach 
if it satisfies the requirements of the applicable statutes and 
regulations.

III. Paperwork Reduction Act of 1995

    This draft guidance refers to previously approved collections of 
information found in FDA regulations. These collections of information 
are subject to review by the Office of Management and Budget (OMB) 
under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The 
collections of information in 21 CFR part 121 have been approved under 
OMB control number 0910-0812.

IV. Electronic Access

    Persons with access to the internet may obtain the draft guidance 
at either https://www.fda.gov/regulatory-information/search-fda-guidance-documents or https://www.regulations.gov. Use the FDA website 
listed in the previous sentence to find the most current version of the 
guidance.

    Dated: February 10, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-02986 Filed 2-13-20; 8:45 am]
 BILLING CODE 4164-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.